These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 17286976)
1. Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands. Cho HJ; Acharjee S; Moon MJ; Oh DY; Vaudry H; Kwon HB; Seong JY Gen Comp Endocrinol; 2007; 153(1-3):98-107. PubMed ID: 17286976 [TBL] [Abstract][Full Text] [Related]
2. Extracellular loop 3 (ECL3) and ECL3-proximal transmembrane domains VI and VII of the mesotocin and vasotocin receptors confer differential ligand selectivity and signaling activity. Cho HJ; Moon MJ; Kwon HB; Hwang JI; Seong JY Gen Comp Endocrinol; 2008 Mar; 156(1):71-82. PubMed ID: 18158152 [TBL] [Abstract][Full Text] [Related]
3. Extracellular loop 3 (EL3) and EL3-proximal transmembrane helix 7 of the mammalian type I and type II gonadotropin-releasing hormone (GnRH) receptors determine differential ligand selectivity to GnRH-I and GnRH-II. Li JH; Choe H; Wang AF; Maiti K; Wang C; Salam A; Chun SY; Lee WK; Kim K; Kwon HB; Seong JY Mol Pharmacol; 2005 Apr; 67(4):1099-110. PubMed ID: 15635044 [TBL] [Abstract][Full Text] [Related]
4. Identification of amino acid residues that direct differential ligand selectivity of mammalian and nonmammalian V1a type receptors for arginine vasopressin and vasotocin. Insights into molecular coevolution of V1a type receptors and their ligands. Acharjee S; Do-Rego JL; Oh DY; Ahn RS; Choe H; Vaudry H; Kim K; Seong JY; Kwon HB J Biol Chem; 2004 Dec; 279(52):54445-53. PubMed ID: 15475353 [TBL] [Abstract][Full Text] [Related]
5. Mini-review: the evolution of neuropeptide signaling. Grimmelikhuijzen CJ; Hauser F Regul Pept; 2012 Aug; 177 Suppl():S6-9. PubMed ID: 22726357 [TBL] [Abstract][Full Text] [Related]
6. Position of Pro and Ser near Glu7.32 in the extracellular loop 3 of mammalian and nonmammalian gonadotropin-releasing hormone (GnRH) receptors is a critical determinant for differential ligand selectivity for mammalian GnRH and chicken GnRH-II. Wang C; Yun O; Maiti K; Oh DY; Kim KK; Chae CH; Lee CJ; Seong JY; Kwon HB Mol Endocrinol; 2004 Jan; 18(1):105-16. PubMed ID: 14525953 [TBL] [Abstract][Full Text] [Related]
7. Pro7.33(303) of the human GnRH receptor regulates selective binding of mammalian GnRH. Fromme BJ; Katz AA; Millar RP; Flanagan CA Mol Cell Endocrinol; 2004 Apr; 219(1-2):47-59. PubMed ID: 15149726 [TBL] [Abstract][Full Text] [Related]
8. Relaxin-3, INSL5, and their receptors. Liu C; Lovenberg TW Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022 [TBL] [Abstract][Full Text] [Related]
10. Involvement of the ser-glu-pro motif in ligand species-dependent desensitisation of the rat gonadotrophin-releasing hormone receptor. Song JA; Oh DY; Moon JS; Geum D; Kwon HB; Seong JY J Neuroendocrinol; 2006 Oct; 18(10):757-66. PubMed ID: 16965294 [TBL] [Abstract][Full Text] [Related]
11. A Gly/Ala switch contributes to high affinity binding of benzoxazinone-based non-peptide oxytocin receptor antagonists. Hawtin SR; Ha SN; Pettibone DJ; Wheatley M FEBS Lett; 2005 Jan; 579(2):349-56. PubMed ID: 15642343 [TBL] [Abstract][Full Text] [Related]
12. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency. Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351 [TBL] [Abstract][Full Text] [Related]
13. Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptor. Betz SF; Reinhart GJ; Lio FM; Chen C; Struthers RS J Med Chem; 2006 Jan; 49(2):637-47. PubMed ID: 16420049 [TBL] [Abstract][Full Text] [Related]
14. Evolution of the AKH/corazonin/ACP/GnRH receptor superfamily and their ligands in the Protostomia. Hauser F; Grimmelikhuijzen CJ Gen Comp Endocrinol; 2014 Dec; 209():35-49. PubMed ID: 25058364 [TBL] [Abstract][Full Text] [Related]
15. Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin. Gimpl G; Postina R; Fahrenholz F; Reinheimer T Eur J Pharmacol; 2005 Mar; 510(1-2):9-16. PubMed ID: 15740719 [TBL] [Abstract][Full Text] [Related]
16. The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors. Perrin MH; Grace CR; Riek R; Vale WW Ann N Y Acad Sci; 2006 Jul; 1070():105-19. PubMed ID: 16888152 [TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis and PBAN activation of the Helicoverpa zea PBAN-receptor. Choi MY; Jurenka RA FEBS Lett; 2010 Mar; 584(6):1212-6. PubMed ID: 20159019 [TBL] [Abstract][Full Text] [Related]